Quote and Research
Join Blog Network
Advertise With Us
Terms and Conditions
China Medical Technologies, Inc. (NASDAQ: CMED)
Current Price :
52 Week Low
52 Week High
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against China Medical Technologies, Inc.
Faruqi & Faruqi, LLP Files Securities Class Action Suit Against China Medical Technologies, Inc. and Certain of Its Executives
Dyer & Berens LLP Announces Class Action on Behalf of China Medical Technologies Investors; Encourages Large Investors to Inquire About the Upcoming Lead Plaintiff Deadline (CMED)
China Medical Technologies Intends to Implement Debt Restructuring
Bronstein, Gewirtz & Grossman, LLC Investigates China Medical Technologies, Inc.
China's Booming Healthcare Sector Poised to Benefit China Medical Technologies and Sinovac Biotech
Faruqi & Faruqi, LLP Announces Investigation of China Medical Technologies, Inc.
China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group
Steps in the Right Direction - Featured Research on Focus Media Holding Limited (ADR) and China Medical Technologies, Inc. (ADR)
China Medical Technologies Announces Payment on Maturity and Cancellation of its 3.5% Convertible Senior Subordinated Notes due November 15, 2011
China Medical Technologies to Announce Results for the Second Fiscal Quarter Ended September 30, 2011 on November 18, 2011
China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Company's Convertible Notes in August 2008
China Medical Technologies Announces the Approval of the Renewed High and New Technology Enterprise Status for a Major Subsidiary in China
China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug
China Medical Technologies Receives Two Patents Granted by the UKIPO and Notice of Allowance for Four Patent Applications from the USPTO
China Medical Technologies Announces the First Inclusion of FISH Tests for Diagnosis of Certain Hematological Malignancies in the Clinical Guidelines Issued by the MOH
China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
China Medical Technologies and Leica Microsystems Announce Collaboration
China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2011 on August 16, 2011
China Medical Technologies Announces Strategic Collaboration Between its Subsidiary, GP Medical, and Da An Health
China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market
China Medical Technologies to Present at Jefferies 2011 Global Healthcare Conference on June 7, 2011
China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2011 on June 2, 2011
Halter USX China Index Up 4.83% for First Quarter 2011
China Medical Technologies to Meet Investors
China Medical Technologies Reports Third Fiscal Quarter Financial Results
China Medical Technologies to Announce Results for the Third Fiscal Quarter Ended December 31, 2010 on February 18, 2011
Halter USX China Index Up 10.73% for 2010
Join Blog Network
| Copyright 2012 all rights reserved
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
. Advertisement partners
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.